SMN1 and cancer: In addition, mechanistic studies on a cellular model of cancer found that nuclear factor (erythroid-derived 2)-like 2 (NRF2) is able to bind two antioxidant-response sites in the SMN1 promoter and that NRF2 transcriptionally controls the production of SMN mRNA.